on 30 Jan 2025
Last Applicant/ Owned by
AstraZeneca AB
SE-151 85 Södertälje
SE
Serial Number
2377181 filed on 11th Dec 2024
Trademark usage description
pharmaceutical preparations and substances.Vienna Information
24 . 15 . 21
Arrowheads -- Note: Not including arrowheads in the form of angles (26.3.23).Pointes de flèches -- Note: Non compris les pointes de flèches en forme d'angles (26.3.23).
26 . 3 . 2
Two triangles, one inside the otherDeux triangles, l'un dans l'autre
26 . 3 . 4
Several triangles, juxtaposed, joined or intersectingPlusieurs triangles, juxtaposés, accolés ou se coupant
26 . 3 . 5
Triangles pointing downwardsTriangles avec la pointe en bas
26 . 3 . 11
Triangles containing one or more quadrilateralsTriangles contenant un ou plusieurs quadrilatères
26 . 3 . 16
Triangles containing other figurative elementsTriangles contenant d'autres éléments figuratifs
26 . 3 . 24
Triangles with dark surfaces or parts of surfacesTriangles avec surface ou partie de la surface foncée
26 . 3 . 26
Triangles with cutout areasTriangles avec des zones découpées
26 . 4 . 4
Other irregular parallelograms, trapezia and quadrilaterals, quadrilaterals containing one or more rounded cornersAutres parallélogrammes, trapèzes et quadrilatères irréguliers, quadrilatères avec un ou plusieurs coins arrondis
26 . 4 . 9
Several quadrilaterals juxtaposed, joined or intersectingPlusieurs quadrilatères, juxtaposés, accolés ou se coupant
26 . 4 . 24
Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée
26 . 7 . 15
Triangles or lines forming an angle with one or more quadrilateralsTriangles ou lignes formant un angle avec un ou plusieurs quadrilatères
12
2377181
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 257 on 30th Jan 2025 | Designation Notification - Madrid Protocol |
Submitted for opposition 1 on 30th Jan 2025 | Created |
Submitted for opposition 31 on 30th Jan 2025 | Formalized |
Submitted for opposition 228 on 11th Dec 2024 | International Registration |
Submitted for opposition 30 on 11th Dec 2024 | Filed |